Literature DB >> 1672600

Efficacy of celiprolol in hypertension and angina pectoris. Introduction.

R J Norris1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1672600     DOI： 10.1007/bf00114218

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN： 0920-3206            Impact factor:   3.727


× No keyword cloud information.
  20 in total

Review 1.  Safety profile of celiprolol.

Authors:  K D Lamon
Journal:  Am Heart J       Date:  1988-11       Impact factor: 4.749

2.  Differential actions of atenolol and celiprolol on cardiac performance in ischemic heart disease.

Authors:  B Silke; S P Verma; M A Frais; G Reynolds; S H Taylor
Journal:  J Cardiovasc Pharmacol       Date:  1986       Impact factor: 3.105

3.  Results of the Austrian celiprolol postmarketing surveillance study.

Authors:  W Hoffmann; H Hoffmann
Journal:  J Cardiovasc Pharmacol       Date:  1986       Impact factor: 3.105

4.  A randomized double-blind study of atenolol and celiprolol in mild to moderate hypertension.

Authors:  B Silke; F Rosenthal; S Taylor
Journal:  J Cardiovasc Pharmacol       Date:  1986       Impact factor: 3.105

5.  Comparison of the acute hemodynamic effects of intravenous celiprolol and propranolol in patients with suspected coronary disease.

Authors:  G Gensini; C Dator; P Esente; F S Caruso; T Solomon
Journal:  J Cardiovasc Pharmacol       Date:  1986       Impact factor: 3.105

6.  A comparison of celiprolol and atenolol in the treatment of hypertension: a placebo controlled double blind study.

Authors:  K Stumpe; R Kolloch; M Mathieu; P Capone
Journal:  Br J Clin Pract Suppl       Date:  1985-06

Review 7.  Hemodynamic aspects of essential hypertension in humans.

Authors:  J Conway
Journal:  Physiol Rev       Date:  1984-04       Impact factor: 37.312

8.  A multi-centre, placebo controlled comparative study between 200 mg and 400 mg celiprolol in patients with mild to moderate essential hypertension.

Authors:  J A Trafford; D Latta; P S Little; J Parsley; S I Ankier; D Quail
Journal:  Curr Med Res Opin       Date:  1989       Impact factor: 2.580

9.  Effects of celiprolol on systemic and forearm circulation in hypertensive patients: a double-blind cross-over study versus metoprolol.

Authors:  B Trimarco; G Lembo; N De Luca; B Ricciardelli; G Rosiello; M Volpe; G Orofino; M Condorelli
Journal:  J Clin Pharmacol       Date:  1987-08       Impact factor: 3.126

10.  Antihypertensive therapy with celiprolol: a new cardioselective beta blocker.

Authors:  R J Norris
Journal:  Am J Cardiol       Date:  1988-02-10       Impact factor: 2.778
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.